Cargando…

Photobiomodulation therapy inhibits oral submucous fibrosis in mice

OBJECTIVES: Oral submucous fibrosis (OSMF) is a chronic inflammatory disease and a potentially malignant oral disorder. However, the best therapeutic treatment for OSMF remains uncertain. Our previous study showed that photobiomodulation (PBM) therapy and forskolin could reduce arecoline‐induced fib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiang, Min‐Hsuan, Lee, Kun‐Tsung, Chen, Chia‐Hsin, Chen, Ker‐Kong, Wang, Yan‐Hsiung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Oral Mucosa
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540580/ https://www.ncbi.nlm.nih.gov/pubmed/32391600 http://dx.doi.org/10.1111/odi.13409

Ejemplares similares

Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft‐versus‐host disease prophylaxis
por: Garming Legert, Karin, et al.
Publicado: (2020)

Prevalence and risk factors of oral mucositis in paediatric patients undergoing haematopoietic stem cell transplantation
por: Alhussain, Abdulmalik, et al.
Publicado: (2021)

A novel method for delineation of oral mucosa for radiotherapy dose–response studies
por: Dean, Jamie A., et al.
Publicado: (2015)

Determination of Effectiveness of Photobiomodulation in the Treatment of Oral Submucous Fibrosis
por: Sukanya, D., et al.
Publicado: (2022)

Characterization of a Novel Dermal Fibrosis Model Induced by Areca Nut Extract that Mimics Oral Submucous Fibrosis
por: Chiang, Min-Hsuan, et al.
Publicado: (2016)

Evaluation of Hematological Profile in Oral Submucous Fibrosis
por: Abidullah, Mohammed, et al.
Publicado: (2022)

Oral mucosal drug delivery
Publicado: (1996)

Diseases of the oral mucosa : a color atlas /
por: Strassburg, Manfred
Publicado: (1994)

Low-power laser irradiation inhibits arecoline-induced fibrosis: an in vitro study
por: Yeh, Mei-Chun, et al.
Publicado: (2017)

Mucosal immunology /
Publicado: (1999)

Estudio epidemiológico de las lesiones de la mucosa oral
por: Ramírez A., Velia A.
Publicado: (1986)

Oral submucous fibrosis: an update
por: Wollina, Uwe, et al.
Publicado: (2015)

Oral submucous fibrosis: An update
por: Ray, Jay Gopal, et al.
Publicado: (2017)

The Effects of Photobiomodulation on Bone Defect Repairing in a Diabetic Rat Model
por: Lee, Ji-Hua, et al.
Publicado: (2021)

Lesiones blancas de la mucosa bucal /
por: Bascones Martínez, Antonio
Publicado: (1992)

VEGF gene transfection restores the angiogenesis of oral submucous fibrosis in mice
por: Sun, Ying, et al.
Publicado: (2021)

Drug treatment for oral submucous fibrosis: an update
por: Chen, Xueru, et al.
Publicado: (2023)

Significantly higher serum tumor marker levels in patients with oral submucous fibrosis
por: Wu, Yu-Hsueh, et al.
Publicado: (2021)

EZBite open-mouth device: A new treatment option for oral submucous fibrosis-related trismus
por: Li, Yu-Hsuan, et al.
Publicado: (2018)

The functional roles of microRNAs in the pathogenesis of oral submucous fibrosis
por: Hsieh, Pei-Ling, et al.
Publicado: (2022)

Lipid profile in oral submucous fibrosis
por: Mehrotra, Ravi, et al.
Publicado: (2009)

Medical management of oral submucous fibrosis
por: Shanbhag, Vagish Kumar Laxman
Publicado: (2015)

Arctigenin Reduces Myofibroblast Activities in Oral Submucous Fibrosis by LINC00974 Inhibition
por: Lin, Ching-Yeh, et al.
Publicado: (2019)

Oral Submucous Fibrosis: A Review on Etiopathogenesis, Diagnosis, and Therapy
por: Shih, Yin-Hwa, et al.
Publicado: (2019)

Management of Oral Submucous Fibrosis with Injection of Hyaluronidase and Dexamethasone in Grade III Oral Submucous Fibrosis: A Retrospective Study
por: James, Leena, et al.
Publicado: (2015)

PTEN and α-SMA Expression and Diagnostic Role in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma with Concomitant Oral Submucous Fibrosis
por: Monteiro, Roshni, et al.
Publicado: (2021)

Submucous fibrosis of the oral cavity. Histomorphological studies.
por: Wahi, P. N., et al.
Publicado: (1966)

Proliferation and apoptosis markers in oral submucous fibrosis
por: Ranganathan, K, et al.
Publicado: (2011)

Oral submucous fibrosis and its dermatological relation
por: Ali, Fareedi Mukram, et al.
Publicado: (2014)

Pathogenesis and therapeutic intervention of oral submucous fibrosis
por: Yoithapprabhunath, Thukanaykanpalayam Ragunathan, et al.
Publicado: (2013)

Immunohistochemical Analysis of Vimentin in Oral Submucous Fibrosis
por: Nayak, Meghanand T., et al.
Publicado: (2013)

Oral submucous fibrosis and plasma lipid profile
por: Pantvaidya, G. H., et al.
Publicado: (2013)

Oral submucous fibrosis: Are we doing enough?
por: Chugh, Ankita, et al.
Publicado: (2019)

Carcinoma Arising in the Background of Oral Submucous Fibrosis
por: Rangaswamy, Shruthi, et al.
Publicado: (2019)

Hematinic deficiencies and anemia in gastric parietal cell antibody-positive and -negative oral submucous fibrosis patients
por: Chiang, Chun-Pin, et al.
Publicado: (2018)

Research Achievements of Oral Submucous Fibrosis: Progress and Prospect
por: Xu, Hui, et al.
Publicado: (2021)

Exploring Possible Diagnostic Precancerous Biomarkers for Oral Submucous Fibrosis: A Narrative Review
por: You, Jie-Ru, et al.
Publicado: (2023)

The Path to an Evidence-Based Treatment Protocol for Extraoral Photobiomodulation Therapy for the Prevention of Oral Mucositis
por: Adnan, Ather, et al.
Publicado: (2021)

Bipaddled anterolateral thigh perforator flap for simultaneous reconstruction of bilateral buccal defects following oral cancer ablation or release of oral submucous fibrosis
por: Chen, Wei-Chen, et al.
Publicado: (2016)

Comparison of Immunohistochemical Markers in Oral Submucous Fibrosis and Oral Submucous Fibrosis Transformed to Oral Squamous Cell Carcinoma—A Systematic Review and Meta-Analysis
por: Mohapatra, Diksha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q333r4roenfs6m6lf4b63skb6p